Anthony E Bolton

Title: **Anthony E Bolton: Innovator in Synthetic Medical Treatments**

Introduction

Anthony E Bolton, a prolific inventor based in Tideswell, GB, has made significant advancements in the field of synthetic medical treatments. With a remarkable portfolio of 17 patents, Bolton's work focuses primarily on the use of apoptosis-mimicking synthetic entities to address various medical disorders.

Latest Patents

Among his latest innovations are two groundbreaking patents aimed at improving patient care. The first patent is for "Apoptosis-mimicking synthetic entities and use thereof in medical treatment." This invention involves synthetic and semisynthetic bodies designed to mimic apoptotic cells, which are administered to patients to alleviate a range of disorders, particularly those related to T-cell mediated autoimmune conditions. These synthetic bodies carry phosphatidyl serine (PS) molecules on their surfaces and act by triggering an apoptosis-like mechanism in the patient.

The second latest patent is titled "Apoptotic entities for use in treatment of endothelium dysfunction disorders." This innovation offers a method for the treatment and prophylaxis of endothelial dysfunction-related disorders in mammalian patients through the administration of effective amounts of apoptotic bodies and/or apoptotic cells.

Career Highlights

Anthony Bolton's career highlights include his tenure at Vasogen Ireland Limited and Vasogen, Inc., where he honed his skills and contributed to pivotal research in the medical field. His dedication to developing synthetic medical solutions has garnered attention and respect in the scientific community.

Collaborations

Throughout his career, Bolton has collaborated with notable coworkers including Arkady Mandel and Alan Drizen. These partnerships have allowed him to exchange ideas and enhance the impact of his inventions.

Conclusion

In summary, Anthony E Bolton stands out as a prominent inventor specializing in synthetic medical treatments. His contributions, particularly in creating synthetic entities that mimic natural apoptotic processes, hold great promise for advancing the treatment of autoimmune conditions and endothelial dysfunction-related disorders. His continued innovation is sure to influence the future of medical science.